ロード中...
Development of ST-246® for Treatment of Poxvirus Infections
ST-246 (Tecovirimat) is a small synthetic antiviral compound being developed to treat pathogenic orthopoxvirus infections of humans. The compound was discovered as part of a high throughput screen designed to identify inhibitors of vaccinia virus-induced cytopathic effects. The antiviral activity is...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Molecular Diversity Preservation International (MDPI)
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3185582/ https://ncbi.nlm.nih.gov/pubmed/21994624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v2112409 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|